Reviva Pharmaceuticals Holdings Stock Alpha and Beta Analysis

RVPHW Stock  USD 0.23  0.04  21.05%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Reviva Pharmaceuticals Holdings. It also helps investors analyze the systematic and unsystematic risks associated with investing in Reviva Pharmaceuticals over a specified time horizon. Remember, high Reviva Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Reviva Pharmaceuticals' market risk premium analysis include:
Beta
(0.30)
Alpha
3.14
Risk
19.56
Sharpe Ratio
0.14
Expected Return
2.81
Please note that although Reviva Pharmaceuticals alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Reviva Pharmaceuticals did 3.14  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Reviva Pharmaceuticals Holdings stock's relative risk over its benchmark. Reviva Pharmaceuticals has a beta of 0.30  . As returns on the market increase, returns on owning Reviva Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Reviva Pharmaceuticals is likely to outperform the market. At this time, Reviva Pharmaceuticals' Book Value Per Share is fairly stable compared to the past year. Tangible Book Value Per Share is likely to climb to 0.45 in 2024, whereas Enterprise Value Over EBITDA is likely to drop (0.000003) in 2024.

Enterprise Value

104.15 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Reviva Pharmaceuticals Backtesting, Reviva Pharmaceuticals Valuation, Reviva Pharmaceuticals Correlation, Reviva Pharmaceuticals Hype Analysis, Reviva Pharmaceuticals Volatility, Reviva Pharmaceuticals History and analyze Reviva Pharmaceuticals Performance.

Reviva Pharmaceuticals Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Reviva Pharmaceuticals market risk premium is the additional return an investor will receive from holding Reviva Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Reviva Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Reviva Pharmaceuticals' performance over market.
α3.14   β-0.3

Reviva Pharmaceuticals expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Reviva Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Reviva Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Reviva Pharmaceuticals Market Price Analysis

Market price analysis indicators help investors to evaluate how Reviva Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Reviva Pharmaceuticals shares will generate the highest return on investment. By understating and applying Reviva Pharmaceuticals stock market price indicators, traders can identify Reviva Pharmaceuticals position entry and exit signals to maximize returns.

Reviva Pharmaceuticals Return and Market Media

The median price of Reviva Pharmaceuticals for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 is 0.13 with a coefficient of variation of 30.94. The daily time series for the period is distributed with a sample standard deviation of 0.04, arithmetic mean of 0.14, and mean deviation of 0.03. The Stock received some media coverage during the period.
 Price Growth (%)  
       Timeline  
1
Reviva Pharmaceuticals Schizophrenia Drug Demonstrates Strong Efficacy On Heels Of Bristol Myers, FDA Approval Analyst - Benzinga
10/07/2024
2
Reviva Pharma to Present Breakthrough Phase 3 Schizophrenia Drug Data at CNS Summit RVPH Stock News - StockTitan
11/06/2024
3
Discretionary transaction by Patel Purav of tradable shares of Reviva Pharmaceuticals subject to Rule 16b-3
11/25/2024

About Reviva Pharmaceuticals Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Reviva or other stocks. Alpha measures the amount that position in Reviva Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Reviva Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Reviva Pharmaceuticals' short interest history, or implied volatility extrapolated from Reviva Pharmaceuticals options trading.

Build Portfolio with Reviva Pharmaceuticals

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Reviva Stock Analysis

When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.